Investigating the prevention and treatment of liver cirrhosis complications
Liver Cirrhosis Network: Longitudinal and Clinical Trial Studies
This study is looking at ways to help people with liver cirrhosis, especially those from high-risk groups, by finding better ways to prevent complications and improve their health outcomes.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-11169371 on NIH RePORTER |
What this research studies
This research focuses on understanding liver cirrhosis, a severe condition resulting from chronic liver injury, and aims to improve patient outcomes through preventative measures. It involves monitoring and screening for complications, addressing risk factors, and exploring potential therapies to halt disease progression. The study particularly emphasizes the impact of social determinants of health on cirrhosis burden among high-risk populations, including racial/ethnic minorities and individuals with substance use disorders. By identifying effective strategies, the research seeks to enhance survival rates and reduce disparities in liver disease management.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with liver cirrhosis, particularly those from high-risk groups such as racial/ethnic minorities and those with substance use disorders.
Not a fit: Patients with early-stage liver disease or those without significant risk factors for cirrhosis may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved prevention and treatment strategies for patients suffering from liver cirrhosis and its complications.
How similar studies have performed: Previous research has shown promising results in addressing liver disease complications through similar preventative and therapeutic approaches.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Khalili, Mandana — University of California, San Francisco
- Study coordinator: Khalili, Mandana
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.